~~<i id='BEF5EB207E'><strike id='BEF5EB207E'><tt id='BEF5EB207E'><pre id='BEF5EB207E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

author：knowledge 2025-10-01 20:16:05 - browse：76465

Lessons Learned is STAT Plus’ weekly column on careers in biomedicine. If you’re thinking of jumping from academics to industry/business or vice versa, join us each week for useful tips. And if you’ve recently jumped, send us a note: kate.she[email protected]. Your experience might make a future column.

Who we talked to:

Lily Ting, 35. Associate, PureTech Health, Boston. Head of R&D, Commense, Boston. Expert, protein-protein interactions. Expert, human-human interactions.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： First over

hotspot

knowledge

hotspot

explore

focus

AdobeOverthelastfewyears,virtualmentalhealthcompanyTalkspacehasbeenonarelentlessquesttoconquertheins

WSS

Longer MASH drug regimen improved liver, Akero study finds

FDA endorses new sterilization method for medical devices

The inclusion problem at the heart of rehabilitation research

A new approach to psychiatric drug development

Medicare drug price negotiation hearing pits pharma v Biden admin

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

focus

focus

hotspot

How to save PrEP access — and even expand it

Families look for replacement for GSK asthma drug Flovent

ChatGPT in medicine: STAT answers readers' burning questions

Microsoft's Peter Lee: Generative AI could help doctors be more human

Medicare details structure of new drug price negotiation program

CVS is on a mission to consolidate health care. Will it work?

Apple is now the first public company to be valued at $3 trillion

Printout prescription drug information shouldn’t go digital

Psychedelics group wrestles with new pharma identity

Florida health officials providing scant details on measles cases

knowledge

Prior authorization reform is both possible and imperative

Longer MASH drug regimen improved liver, Akero study finds

HPV vaccine, cervical cancer study delivers historic results

Maisha Meds is a PBM, but don't call it that

High breast density mammograms need follow

The inclusion problem at the heart of rehabilitation research

hotspot

explore

focus

focus